Dudediligence.

BeOne Medicines AG

ONCNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$406.1M

45 notices · 1,266,627 sh

Oct 2025 to Oct 2026

Reported ·

$51.8M

92 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

38 of 92 reported sales carry the 10b5-1 box. Together they are 0.01% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-30: CHAN LEE, Form 1442026-09-08: XIAODONG WANG, Form 1442026-09-01: TITUS BENJAMIN BALL, Form 1442026-08-25: XIAOBIN WU, Form 1442026-08-25: CORAZON D. SANDERS, Form 1442026-08-11: CHAN LEE, Form 1442026-08-10: JOHN V OYLER, Form 1442026-08-03: AARON ROSENBERG, Form 1442026-07-30: CHAN LEE, Form 1442026-07-22: CHAN LEE, Form 1442026-07-14: JOHN V OYLER, Form 1442026-07-10: JOHN V OYLER, Form 1442026-07-10: PAN-OYLER FOUNDATION, Form 1442026-06-23: LAI WANG, Form 1442026-06-23: XIAOBIN WU, Form 1442026-06-23: JOHN OYLER, Form 1442026-06-16: CHAN LEE, Form 1442026-06-16: LAI WANG, Form 1442026-06-16: XIAOBIN WU, Form 1442026-06-16: JOHN OYLER, Form 1442026-06-15: CORAZON D. SANDERS, Form 1442026-06-11: XIAOBIN WU, Form 1442026-06-11: LAI WANG, Form 1442026-06-11: AARON ROSENBERG, Form 1442026-06-11: TITUS BENJAMIN BALL, Form 1442026-06-11: CHAN LEE, Form 1442026-06-11: JOHN OYLER, Form 1442026-06-08: TITUS BENJAMIN BALL, Form 1442026-06-08: CHAN LEE, Form 1442026-06-08: LAI WANG, Form 1442026-06-08: XIAOBIN WU, Form 1442026-06-08: JOHN OYLER, Form 1442026-06-01: QINGQING YI, Form 1442026-05-22: MICHAEL GOLLER, Form 1442026-05-22: RANJEEV KRISHANA, Form 1442026-05-22: ALESSANDRO RIVA, Form 1442026-05-22: MARGARET DUGAN, Form 1442026-05-22: CORAZON D. SANDERS, Form 1442026-05-13: CHAN LEE, Form 1442026-02-04: CHAN LEE, Form 1442025-12-15: JOHN V OYLER, Form 1442025-11-26: CORAZON D. SANDERS, Form 1442025-11-17: XIAOBIN WU, Form 1442025-11-13: XIAOBIN WU, Form 1442025-11-12: XIAOBIN WU, Form 1442025-10-08: Lee Chan Henry, sold2025-11-12: Wu Xiaobin, sold2025-11-12: Lee Chan Henry, sold2025-11-17: Wu Xiaobin, sold2025-11-26: Sanders Corazon (Corsee) D., sold2025-12-10: Lee Chan Henry, sold2025-12-15: OYLER JOHN, sold2026-01-07: Lee Chan Henry, sold2026-02-04: Lee Chan Henry, sold2026-03-11: Lee Chan Henry, sold2026-04-08: Lee Chan Henry, sold2026-05-13: Lee Chan Henry, sold2026-05-22: BAKER JULIAN, sold2026-05-22: Sanders Corazon (Corsee) D., sold2026-05-22: Riva Alessandro, sold2026-05-22: Dugan Margaret, sold2026-06-01: Yi Qingqing, sold2026-06-08: OYLER JOHN, sold2026-06-08: Ball Titus B., sold2026-06-08: Wu Xiaobin, sold2026-06-08: Wang Lai, sold2026-06-08: Lee Chan Henry, sold2026-06-11: OYLER JOHN, sold2026-06-11: Ball Titus B., sold2026-06-11: Wu Xiaobin, sold2026-06-11: Wang Lai, sold2026-06-11: Lee Chan Henry, sold2026-06-11: Rosenberg Aaron, sold2026-06-16: OYLER JOHN, sold2026-06-16: Wu Xiaobin, sold2026-06-16: Wang Lai, sold2026-06-16: Lee Chan Henry, sold2026-06-23: OYLER JOHN, sold2026-06-23: Wu Xiaobin, sold2026-06-23: Wang Lai, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-30CHAN LEE, SVP, General Counsel$407,276
1,115 shplan 2026-05-29Form 4s on file end Jun 23144 ↗
2026-09-08XIAODONG WANG, Director, Chair, Scientific Advisory Brd$47.1M
131,370 shplan 2026-06-09Form 4s on file end Jun 23144 ↗
2026-09-01TITUS BENJAMIN BALL, Principal Accounting Officer$46,974
132 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-25XIAOBIN WU, President and COO$5,579,700
15,000 shplan 2025-11-07Form 4s on file end Jun 23144 ↗
2026-08-25CORAZON D. SANDERS, Former Director$788,500
2,075 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-11CHAN LEE, SVP, General Counsel$718,718
2,002 shplan 2025-05-14Form 4s on file end Jun 23144 ↗
2026-08-10JOHN V OYLER, Chief Executive Officer$83.9M
240,810 shplan 2026-03-10Form 4s on file end Jun 23144 ↗
2026-08-03AARON ROSENBERG, Chief Financial Officer$361,811
1,157 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-30CHAN LEE, SVP, General Counsel$337,932
1,044 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-22CHAN LEE, SVP, General Counsel$637,689
2,001 shplan 2025-05-14Form 4s on file end Jun 23144 ↗
2026-07-14JOHN V OYLER, Chief Executive Officer$156.1M
513,574 shplan 2026-03-10Form 4s on file end Jun 23144 ↗
2026-07-10JOHN V OYLER, Chief Executive Officer$45.4M
150,000 shplan 2026-03-10Form 4s on file end Jun 23144 ↗
2026-07-10PAN-OYLER FOUNDATION, Chief Executive Officer$15.0M
49,541 shplan 2026-03-10Form 4s on file end Jun 23144 ↗
2026-06-23LAI WANG, President, Global Head of R&D$295,553
1,068 shno plan date144 ↗
Form 4, 2026-06-25: sold 1,068 at $276.74 Form 4 ↗
2026-06-23XIAOBIN WU, President and COO$356,927
1,292 shno plan date144 ↗
Form 4, 2026-06-25: sold 1,292 at $276.26 Form 4 ↗
2026-06-23JOHN OYLER, Chief Executive Officer$933,592
3,410 shno plan date144 ↗
Form 4, 2026-06-25: sold 3,410 at $273.78 Form 4 ↗
2026-06-16CHAN LEE, SVP, General Counsel$156,925
590 shno plan date144 ↗
Form 4, 2026-06-18: sold 590 at $265.98 Form 4 ↗
2026-06-16LAI WANG, President, Global Head of R&D$310,236
1,169 shno plan date144 ↗
Form 4, 2026-06-18: sold 1,169 at $265.39 Form 4 ↗
2026-06-16XIAOBIN WU, President and COO$361,997
1,357 shno plan date144 ↗
Form 4, 2026-06-18: sold 1,357 at $266.76 Form 4 ↗
2026-06-16JOHN OYLER, Chief Executive Officer$980,686
3,693 shno plan date144 ↗
Form 4, 2026-06-18: sold 3,693 at $265.55 Form 4 ↗
2026-06-15CORAZON D. SANDERS, Director$250,894
945 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-11XIAOBIN WU, President and COO$163,512
626 shno plan date144 ↗
Form 4, 2026-06-15: sold 626 at $261.20 Form 4 ↗
2026-06-11LAI WANG, President, Global Head of R&D$197,630
756 shno plan date144 ↗
Form 4, 2026-06-15: sold 756 at $261.00 Form 4 ↗
2026-06-11AARON ROSENBERG, Chief Financial Officer$162,637
631 shno plan date144 ↗
Form 4, 2026-06-15: sold 631 at $257.74 Form 4 ↗
2026-06-11TITUS BENJAMIN BALL, Principal Accounting Officer$43,467
169 shno plan date144 ↗
Form 4, 2026-06-15: sold 169 at $257.20 Form 4 ↗
2026-06-11CHAN LEE, SVP, General Counsel$110,268
428 shno plan date144 ↗
Form 4, 2026-06-15: sold 428 at $257.64 Form 4 ↗
2026-06-11JOHN OYLER, Chief Executive Officer$501,355
1,949 shno plan date144 ↗
Form 4, 2026-06-15: sold 1,949 at $257.24 Form 4 ↗
2026-06-08TITUS BENJAMIN BALL, Principal Accounting Officer$36,901
136 shno plan date144 ↗
Form 4, 2026-06-10: sold 136 at $271.33 Form 4 ↗
2026-06-08CHAN LEE, SVP, General Counsel$235,539
871 shno plan date144 ↗
Form 4, 2026-06-10: sold 871 at $270.43 Form 4 ↗
2026-06-08LAI WANG, President, Global Head of R&D$368,247
1,367 shno plan date144 ↗
Form 4, 2026-06-10: sold 1,367 at $269.38 Form 4 ↗
2026-06-08XIAOBIN WU, President and COO$399,738
1,484 shno plan date144 ↗
Form 4, 2026-06-10: sold 1,484 at $269.36 Form 4 ↗
2026-06-08JOHN OYLER, Chief Executive Officer$1,336,548
4,940 shno plan date144 ↗
Form 4, 2026-06-10: sold 4,940 at $270.55 Form 4 ↗
2026-06-01QINGQING YI, Director$65,596
235 shno plan date144 ↗
Form 4, 2026-06-03: sold 235 at $279.13 Form 4 ↗
2026-05-22MICHAEL GOLLER, Director$65,424
211 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-22RANJEEV KRISHANA, Director$65,567
212 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-22ALESSANDRO RIVA, Director$65,617
212 shno plan date144 ↗
Form 4, 2026-05-27: sold 212 at $309.51 Form 4 ↗
2026-05-22MARGARET DUGAN, Director$65,636
212 shno plan date144 ↗
Form 4, 2026-05-27: sold 212 at $309.60 Form 4 ↗
2026-05-22CORAZON D. SANDERS, Director$65,633
212 shno plan date144 ↗
Form 4, 2026-05-27: sold 212 at $309.59 Form 4 ↗
2026-05-13CHAN LEE, SVP, General Counsel$418,413
1,328 shplan 2025-05-14144 ↗
Form 4, 2026-05-15: sold 332 at $310.72 Form 4 ↗
2026-02-04CHAN LEE, SVP, General Counsel$1,619,673
4,676 shplan 2025-05-14144 ↗
Form 4, 2026-02-06: sold 1,660 at $349.52 Form 4 ↗
2025-12-15JOHN V OYLER, Chief Executive Officer$31.9M
100,000 shplan 2025-03-12144 ↗
Form 4, 2025-12-17: sold 100,000 at $306.59 Form 4 ↗
2025-11-26CORAZON D. SANDERS, Director$895,535
2,627 shno plan date144 ↗
Form 4, 2025-12-01: sold 2,627 at $340.89 Form 4 ↗
2025-11-17XIAOBIN WU, President and COO$1,518,303
3,991 shno plan date144 ↗
Form 4, 2025-11-19: sold 3,991 at $380.43 Form 4 ↗
2025-11-13XIAOBIN WU, President and COO$2,286,659
6,009 shno plan dateno Form 4 on file144 ↗
2025-11-12XIAOBIN WU, President and COO$3,560,161
10,000 shno plan date144 ↗
Form 4, 2025-11-14: sold 16,009 at $365.22 Form 4 ↗